-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$34.003.19% Upside
LENZ Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Citigroup in the past 90 days.